{"gene":"CRTAP","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2024,"finding":"Cryo-EM structures of the P3H1/CRTAP/PPIB ternary complex reveal that the active sites of P3H1 and PPIB form a face-to-face bifunctional reaction center, indicating a coupled collagen modification mechanism. A structure with bound collagen peptide reveals multiple substrate-binding sites forming a substrate-interacting zone. An unexpected dual-ternary complex was also observed, whose equilibrium with the ternary state can be altered by mutations at the P3H1/PPIB active site or addition of PPIB inhibitors.","method":"Cryo-EM structure determination, active-site mutagenesis, collagen peptide co-complex","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure with collagen peptide co-complex and mutagenesis in a single rigorous study","pmids":["39245686"],"is_preprint":false},{"year":2009,"finding":"CRTAP and P3H1 are mutually stabilized at the protein level within the ER collagen prolyl 3-hydroxylation complex: null mutations in either gene cause loss of both proteins (despite normal mRNA of the unaffected gene), and stable transfection of the missing cDNA restores both protein levels and Pro986 3-hydroxylation activity. Proteasomal inhibitors partially rescue P3H1 in CRTAP-null cells, indicating proteasome-mediated degradation of the unstabilized partner.","method":"Western blot, immunofluorescence, stable transfection rescue, proteasomal inhibitor treatment in patient fibroblasts","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal protein-level rescue by transfection plus proteasome inhibitor experiments, multiple orthogonal methods in one study","pmids":["19846465"],"is_preprint":false},{"year":2008,"finding":"CRTAP and P3H1 (LEPRE1) form a complex that catalyzes 3-hydroxylation of Pro986 in the α1(I) and α1(II) collagen chains and recruits cyclophilin B (CYPB) to unfolded collagen. Loss-of-function mutations in CRTAP abolish this hydroxylation.","method":"Biochemical analysis of collagen from patient fibroblasts with CRTAP mutations; complex composition determined by prior biochemical studies cited","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple patient cell lines with null mutations and biochemical collagen analysis, consistent with parallel literature","pmids":["18566967"],"is_preprint":false},{"year":2009,"finding":"CRTAP, P3H1, and cyclophilin B (PPIB) comprise the collagen prolyl 3-hydroxylation complex in the ER. Absence of CRTAP or P3H1 leads to overmodification of the type I collagen helical region (by lysyl hydroxylase and prolyl 4-hydroxylase), indicating substantially delayed collagen helix folding.","method":"Biochemical collagen analysis from patient cells and Crtap-/- mice; SDS-PAGE migration shift assay for collagen overmodification","journal":"Cell and tissue research","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated across multiple labs and patient cohorts using biochemical collagen modification assays","pmids":["19862557"],"is_preprint":false},{"year":2010,"finding":"CRTAP and P3H1 are required to maintain a stable complex that 3-hydroxylates Pro986 in clade A collagen chains (types I, II, and V). Loss of CRTAP also abolishes 3-hydroxylation at Pro986 in α2(V) chains, but does not affect 3-hydroxylation at two known sites in α1(IV) chains, indicating substrate specificity of the complex for fibrillar collagens.","method":"Mass spectrometry-based collagen hydroxyproline analysis from Crtap-/- mouse tissues (lung, kidney) and human OI fibroblasts","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — MS-based site-specific hydroxylation mapping in mouse KO and human patient cells, replicated substrate specificity finding","pmids":["20485499"],"is_preprint":false},{"year":2011,"finding":"CRTAP deficiency reduces deposition of type I collagen into the extracellular matrix (to 10–15% of control) and causes disorganization of the fibrillar network and increased collagen fibril diameters, demonstrating a chaperone/matrix-assembly role for CRTAP beyond intracellular hydroxylation.","method":"Immunofluorescence of long-term fibroblast cultures, quantitative pulse-chase experiments, electron microscopy of dermal collagen fibrils","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal methods (pulse-chase and immunofluorescence) in a single patient cell line","pmids":["21955071"],"is_preprint":false},{"year":2020,"finding":"In zebrafish lacking crtap (CRISPR/Cas9 knockout), type I collagen is intracellularly overmodified and partially retained in enlarged ER cisternae, and extracellular collagen assembles into disorganized fibers with altered fibril diameter, supporting the complex's primary role as a collagen chaperone rather than solely a hydroxylase.","method":"CRISPR/Cas9 knockout zebrafish, transmission electron microscopy, collagen biochemical analysis","journal":"Matrix biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple orthogonal readouts (EM ultrastructure, biochemical modification analysis) in a vertebrate model","pmids":["32173581"],"is_preprint":false},{"year":2023,"finding":"Deep intronic CRTAP mutations generate unstable truncated/aberrant isoforms containing a 'GWxxI' degron sequence, leading to protein instability, loss of Pro986 hydroxylation, type I collagen aggregation, and cell death by senescence. Collagen aggregates are partially cleared by autophagy.","method":"Genome sequencing, minigene splicing assay, western blot of patient cells, collagen aggregation assay, autophagy inhibition experiments","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single patient cell line, multiple biochemical methods but not independently replicated","pmids":["37146916"],"is_preprint":false},{"year":1999,"finding":"Human CRTAP (CASP) encodes a novel cartilage-associated protein with high sequence identity to mouse and lower identity to chick orthologs; the gene is expressed in cartilage and maps to chromosome 3p22; CRTAP protein is related to but distinct from certain nuclear proteins, defining a new protein family.","method":"cDNA cloning, Northern blot, FISH chromosome mapping, immunohistochemistry","journal":"Cytogenetics and cell genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct experimental characterization including FISH mapping and immunohistochemistry in multiple tissues","pmids":["10702664"],"is_preprint":false},{"year":2009,"finding":"CRTAP deficiency (in Crtap-/- mice and OI type VII patients) results in significantly elevated bone matrix mineral content and altered mineralization kinetics, with increased proportions of highly mineralized matrix and primary bone persistence, indicating that abnormal collagen modification secondary to CRTAP loss directly perturbs bone mineralization.","method":"Quantitative backscattered electron imaging (qBEI) of mouse femurs and human bone biopsies","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative imaging in both mouse KO and human patient biopsies, consistent findings across species","pmids":["19895918"],"is_preprint":false},{"year":2021,"finding":"Crtap-/- mouse tendons show reduced collagen fibril size, increased collagen cross-links, and altered progenitor cell populations, with dysregulated TGF-β, inflammatory, and metabolic signaling by RNA-seq, and increased αSMA, MMP2, and phospho-NFκB staining indicating excess matrix remodeling and tissue inflammation.","method":"Mechanical testing of isolated tendons, electron microscopy, RNA-seq, immunostaining, flow cytometry of tendon progenitor cells, behavioral motor testing","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods in mouse KO model, single lab","pmids":["34036937"],"is_preprint":false},{"year":2024,"finding":"Biallelic CRTAP mutations reduce CRTAP mRNA and protein in osteoblasts, leading to significantly reduced prolyl 3-hydroxylation at Pro986 of the α1(I) collagen chain, reduced osteoid volume, and reduced osteoblast numbers, directly linking CRTAP function in osteoblasts to active bone formation.","method":"Bone biopsy immunostaining, RT-PCR, western blot, mass spectrometry of collagen hydroxylation in patient osteoblasts","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct patient bone specimen analysis with multiple methods but single patient sample","pmids":["38214665"],"is_preprint":false}],"current_model":"CRTAP is an essential non-enzymatic scaffold component of the ER-resident P3H1/CRTAP/PPIB ternary complex, which—as revealed by cryo-EM—positions the P3H1 hydroxylase and PPIB isomerase active sites in a face-to-face bifunctional reaction center to perform coupled prolyl 3-hydroxylation and cis-trans isomerization of Pro986 in fibrillar (clade A: type I, II, V) collagen α1 chains; CRTAP and P3H1 mutually stabilize each other post-translationally via proteasome-dependent degradation when either partner is absent, and loss of CRTAP additionally impairs collagen chaperoning, causing intracellular collagen overmodification, delayed helix folding, deficient extracellular matrix deposition, and disorganized collagen fibrils, collectively producing the severe recessive osteogenesis imperfecta (type VII) phenotype."},"narrative":{"mechanistic_narrative":"CRTAP is an essential ER-resident component of the collagen prolyl 3-hydroxylation machinery, where it assembles with the P3H1 hydroxylase and the PPIB (cyclophilin B) isomerase into a ternary complex that modifies fibrillar collagen during biosynthesis [PMID:18566967, PMID:19862557]. Cryo-EM of the P3H1/CRTAP/PPIB complex shows the P3H1 and PPIB active sites arranged face-to-face into a bifunctional reaction center with a multi-site collagen substrate-interacting zone, defining a coupled hydroxylation–isomerization mechanism [PMID:39245686]. The complex 3-hydroxylates Pro986 of clade A (type I, II, V) collagen α1 chains, and loss of CRTAP abolishes this site-specific modification while leaving non-fibrillar α1(IV) sites unaffected, establishing its substrate specificity [PMID:20485499]. CRTAP and P3H1 mutually stabilize one another post-translationally: absence of either triggers proteasome-mediated degradation of the partner, and re-expression restores both protein levels and Pro986 hydroxylation [PMID:19846465]. Beyond hydroxylation, CRTAP acts as a collagen chaperone; its loss causes intracellular collagen overmodification and delayed helix folding, ER retention and aggregation, deficient extracellular matrix deposition, and disorganized fibrils of altered diameter [PMID:19862557, PMID:21955071, PMID:32173581]. These defects perturb bone mineralization and osteoblast-driven bone formation, and biallelic CRTAP mutations produce a severe recessive osteogenesis imperfecta phenotype [PMID:19895918, PMID:38214665].","teleology":[{"year":1999,"claim":"Established CRTAP as a novel cartilage-expressed protein and defined it as a new gene/protein family, providing the molecular entity later linked to collagen biology.","evidence":"cDNA cloning, Northern blot, FISH mapping to 3p22, and immunohistochemistry across tissues","pmids":["10702664"],"confidence":"Medium","gaps":["No biochemical function assigned at this stage","No interaction partners identified","Relationship to collagen modification unknown"]},{"year":2008,"claim":"Showed CRTAP is not an isolated protein but part of a complex with P3H1 that 3-hydroxylates Pro986 in α1(I)/α1(II) collagen and recruits cyclophilin B, defining its catalytic context.","evidence":"Biochemical collagen analysis of patient fibroblasts carrying CRTAP loss-of-function mutations","pmids":["18566967"],"confidence":"Medium","gaps":["CRTAP's own enzymatic role within the complex not resolved","Stoichiometry and assembly mechanism unknown","No structural basis for catalysis"]},{"year":2009,"claim":"Resolved how CRTAP and P3H1 depend on each other by demonstrating reciprocal post-translational stabilization, explaining why mutation in one gene eliminates both proteins.","evidence":"Western blot, immunofluorescence, transfection rescue, and proteasome inhibition in patient fibroblasts; biochemical collagen overmodification analysis in patient cells and Crtap-/- mice","pmids":["19846465","19862557"],"confidence":"High","gaps":["The degradation signal/machinery targeting the unstabilized partner not defined","Quantitative contribution of hydroxylation vs folding delay to overmodification unclear"]},{"year":2010,"claim":"Defined the substrate range of the CRTAP-containing complex by mapping which collagen Pro residues require CRTAP, establishing specificity for fibrillar (clade A) collagens.","evidence":"Mass spectrometry hydroxyproline mapping in Crtap-/- mouse tissues and human OI fibroblasts","pmids":["20485499"],"confidence":"High","gaps":["Determinants of site selectivity within collagen sequences not defined","Whether CRTAP contributes binding specificity vs P3H1 unknown"]},{"year":2011,"claim":"Extended CRTAP's role beyond hydroxylation to matrix assembly, showing its loss reduces ECM collagen deposition and disorganizes the fibrillar network, implicating a chaperone function.","evidence":"Immunofluorescence, quantitative pulse-chase, and electron microscopy in patient fibroblasts","pmids":["21955071"],"confidence":"Medium","gaps":["Single patient cell line","Molecular basis of chaperone activity not defined","Whether matrix defect is direct or secondary to overmodification unclear"]},{"year":2020,"claim":"Confirmed the chaperone-dominant role in a vertebrate genetic model, showing intracellular collagen overmodification, ER retention, and disorganized extracellular fibrils upon crtap loss.","evidence":"CRISPR/Cas9 crtap-knockout zebrafish with TEM and collagen biochemical analysis","pmids":["32173581"],"confidence":"High","gaps":["Relative weighting of hydroxylase vs chaperone contributions to phenotype not quantified","Mechanism of ER retention not defined"]},{"year":2023,"claim":"Identified a degron-based mechanism by which deep intronic mutations destabilize CRTAP, linking protein instability to collagen aggregation, senescence, and autophagic clearance.","evidence":"Genome sequencing, minigene splicing assays, western blot, collagen aggregation and autophagy inhibition experiments in patient cells","pmids":["37146916"],"confidence":"Medium","gaps":["Single patient cell line, not independently replicated","Generality of the GWxxI degron to other variants unknown","Mechanistic basis of senescence not defined"]},{"year":2024,"claim":"Provided the structural basis of CRTAP function, showing it scaffolds P3H1 and PPIB active sites into a face-to-face bifunctional center, revealing a coupled hydroxylation–isomerization mechanism.","evidence":"Cryo-EM of the P3H1/CRTAP/PPIB ternary complex with collagen peptide co-complex and active-site mutagenesis","pmids":["39245686"],"confidence":"High","gaps":["Functional role of the observed dual-ternary complex equilibrium not established","Catalytic order/coupling kinetics not measured","CRTAP's direct contribution to substrate binding vs scaffolding not separated"]},{"year":2024,"claim":"Tied CRTAP function directly to bone-forming cells, showing reduced osteoblast hydroxylation activity, osteoid volume, and osteoblast number in patient bone.","evidence":"Bone biopsy immunostaining, RT-PCR, western blot, and mass spectrometry of collagen hydroxylation in patient osteoblasts","pmids":["38214665"],"confidence":"Medium","gaps":["Single patient sample","Causal chain from collagen defect to reduced osteoblast number not resolved","Cell-autonomous vs systemic effects not separated"]},{"year":null,"claim":"How CRTAP's distinct activities — scaffolding the bifunctional reaction center, mutual stabilization of P3H1, and collagen chaperoning — are mechanistically separable and individually contribute to the osteogenesis imperfecta phenotype remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No separation-of-function alleles isolating hydroxylase vs chaperone roles","Functional meaning of the dual-ternary complex equilibrium unknown","Mechanism linking collagen defect to mineralization abnormality undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[5,6]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[3,6]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[5,6]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,2,4]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[9,11]}],"complexes":["P3H1/CRTAP/PPIB collagen prolyl 3-hydroxylation complex"],"partners":["P3H1","PPIB"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O75718","full_name":"Cartilage-associated protein","aliases":[],"length_aa":401,"mass_kda":46.6,"function":"Necessary for efficient 3-hydroxylation of fibrillar collagen prolyl residues","subcellular_location":"Secreted, extracellular space, extracellular matrix","url":"https://www.uniprot.org/uniprotkb/O75718/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CRTAP","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CPSF6","stoichiometry":10.0},{"gene":"SF3B4","stoichiometry":0.2},{"gene":"SNRPA","stoichiometry":0.2},{"gene":"SNRPF","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CRTAP","total_profiled":1310},"omim":[{"mim_id":"615066","title":"OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14","url":"https://www.omim.org/entry/615066"},{"mim_id":"610915","title":"OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8","url":"https://www.omim.org/entry/610915"},{"mim_id":"610682","title":"OSTEOGENESIS IMPERFECTA, TYPE VII; OI7","url":"https://www.omim.org/entry/610682"},{"mim_id":"610339","title":"PROLYL 3-HYDROXYLASE 1; P3H1","url":"https://www.omim.org/entry/610339"},{"mim_id":"605497","title":"CARTILAGE-ASSOCIATED PROTEIN; CRTAP","url":"https://www.omim.org/entry/605497"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Intermediate filaments","reliability":"Approved"},{"location":"Actin filaments","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CRTAP"},"hgnc":{"alias_symbol":["CASP","LEPREL3","P3H5"],"prev_symbol":[]},"alphafold":{"accession":"O75718","domains":[{"cath_id":"1.25.40","chopping":"45-92_119-198","consensus_level":"medium","plddt":94.9923,"start":45,"end":198},{"cath_id":"-","chopping":"206-380","consensus_level":"high","plddt":95.257,"start":206,"end":380}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75718","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75718-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75718-F1-predicted_aligned_error_v6.png","plddt_mean":88.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CRTAP","jax_strain_url":"https://www.jax.org/strain/search?query=CRTAP"},"sequence":{"accession":"O75718","fasta_url":"https://rest.uniprot.org/uniprotkb/O75718.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75718/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75718"}},"corpus_meta":[{"pmid":"18566967","id":"PMC_18566967","title":"CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta.","date":"2008","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18566967","citation_count":173,"is_preprint":false},{"pmid":"19862557","id":"PMC_19862557","title":"Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta.","date":"2009","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/19862557","citation_count":85,"is_preprint":false},{"pmid":"26716893","id":"PMC_26716893","title":"Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta.","date":"2016","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/26716893","citation_count":68,"is_preprint":false},{"pmid":"19846465","id":"PMC_19846465","title":"Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19846465","citation_count":62,"is_preprint":false},{"pmid":"19895918","id":"PMC_19895918","title":"CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.","date":"2009","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/19895918","citation_count":57,"is_preprint":false},{"pmid":"20485499","id":"PMC_20485499","title":"Generalized connective tissue disease in Crtap-/- mouse.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20485499","citation_count":52,"is_preprint":false},{"pmid":"19550437","id":"PMC_19550437","title":"CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis.","date":"2009","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/19550437","citation_count":40,"is_preprint":false},{"pmid":"32173581","id":"PMC_32173581","title":"Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype.","date":"2020","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32173581","citation_count":34,"is_preprint":false},{"pmid":"21955071","id":"PMC_21955071","title":"Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix.","date":"2011","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21955071","citation_count":24,"is_preprint":false},{"pmid":"21964860","id":"PMC_21964860","title":"Severe osteogenesis imperfecta caused by a small in-frame deletion in CRTAP.","date":"2011","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21964860","citation_count":20,"is_preprint":false},{"pmid":"37146916","id":"PMC_37146916","title":"Deep intronic mutation in CRTAP results in unstable isoforms of the protein to induce type I collagen aggregation in a lethal type of osteogenesis imperfecta type VII.","date":"2023","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/37146916","citation_count":19,"is_preprint":false},{"pmid":"32133710","id":"PMC_32133710","title":"Dental and craniofacial defects in the Crtap-/- mouse model of osteogenesis imperfecta type VII.","date":"2020","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/32133710","citation_count":18,"is_preprint":false},{"pmid":"10429950","id":"PMC_10429950","title":"cDNA cloning, characterization and chromosome mapping of Crtap encoding the mouse cartilage associated protein.","date":"1999","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/10429950","citation_count":18,"is_preprint":false},{"pmid":"25604815","id":"PMC_25604815","title":"CRTAP mutation in a patient with Cole-Carpenter syndrome.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25604815","citation_count":17,"is_preprint":false},{"pmid":"26634552","id":"PMC_26634552","title":"Mutational characterization of the P3H1/CRTAP/CypB complex in recessive osteogenesis imperfecta.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26634552","citation_count":16,"is_preprint":false},{"pmid":"34036937","id":"PMC_34036937","title":"Tendon and motor phenotypes in the Crtap mouse model of recessive osteogenesis imperfecta.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34036937","citation_count":16,"is_preprint":false},{"pmid":"39245686","id":"PMC_39245686","title":"The structural basis for the collagen processing by human P3H1/CRTAP/PPIB ternary complex.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39245686","citation_count":11,"is_preprint":false},{"pmid":"10702664","id":"PMC_10702664","title":"cDNA cloning, characterization and chromosome mapping of the gene encoding human cartilage associated protein (CRTAP).","date":"1999","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10702664","citation_count":11,"is_preprint":false},{"pmid":"19727905","id":"PMC_19727905","title":"Common variants in FLNB/CRTAP, not ARHGEF3 at 3p, are associated with osteoporosis in southern Chinese women.","date":"2009","source":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","url":"https://pubmed.ncbi.nlm.nih.gov/19727905","citation_count":11,"is_preprint":false},{"pmid":"32922437","id":"PMC_32922437","title":"Novel Compound Heterozygous Mutations in CRTAP Cause Rare Autosomal Recessive Osteogenesis Imperfecta.","date":"2020","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32922437","citation_count":8,"is_preprint":false},{"pmid":"38214665","id":"PMC_38214665","title":"Genetic Analysis, Phenotypic Spectrum and Functional Study of Rare Osteogenesis Imperfecta Caused by CRTAP Variants.","date":"2024","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/38214665","citation_count":5,"is_preprint":false},{"pmid":"35970273","id":"PMC_35970273","title":"Craniofacial and dental phenotype of two girls with osteogenesis imperfecta due to mutations in CRTAP.","date":"2022","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/35970273","citation_count":4,"is_preprint":false},{"pmid":"41064055","id":"PMC_41064055","title":"CRTAP-Related Osteogenesis Imperfecta: Clinical Variability and a Potential Founder Variant in CRTAP.","date":"2025","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/41064055","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13878,"output_tokens":2982,"usd":0.043182,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10471,"output_tokens":3271,"usd":0.067065,"stage2_stop_reason":"end_turn"},"total_usd":0.110247,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2024,\n      \"finding\": \"Cryo-EM structures of the P3H1/CRTAP/PPIB ternary complex reveal that the active sites of P3H1 and PPIB form a face-to-face bifunctional reaction center, indicating a coupled collagen modification mechanism. A structure with bound collagen peptide reveals multiple substrate-binding sites forming a substrate-interacting zone. An unexpected dual-ternary complex was also observed, whose equilibrium with the ternary state can be altered by mutations at the P3H1/PPIB active site or addition of PPIB inhibitors.\",\n      \"method\": \"Cryo-EM structure determination, active-site mutagenesis, collagen peptide co-complex\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure with collagen peptide co-complex and mutagenesis in a single rigorous study\",\n      \"pmids\": [\"39245686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CRTAP and P3H1 are mutually stabilized at the protein level within the ER collagen prolyl 3-hydroxylation complex: null mutations in either gene cause loss of both proteins (despite normal mRNA of the unaffected gene), and stable transfection of the missing cDNA restores both protein levels and Pro986 3-hydroxylation activity. Proteasomal inhibitors partially rescue P3H1 in CRTAP-null cells, indicating proteasome-mediated degradation of the unstabilized partner.\",\n      \"method\": \"Western blot, immunofluorescence, stable transfection rescue, proteasomal inhibitor treatment in patient fibroblasts\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal protein-level rescue by transfection plus proteasome inhibitor experiments, multiple orthogonal methods in one study\",\n      \"pmids\": [\"19846465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CRTAP and P3H1 (LEPRE1) form a complex that catalyzes 3-hydroxylation of Pro986 in the α1(I) and α1(II) collagen chains and recruits cyclophilin B (CYPB) to unfolded collagen. Loss-of-function mutations in CRTAP abolish this hydroxylation.\",\n      \"method\": \"Biochemical analysis of collagen from patient fibroblasts with CRTAP mutations; complex composition determined by prior biochemical studies cited\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple patient cell lines with null mutations and biochemical collagen analysis, consistent with parallel literature\",\n      \"pmids\": [\"18566967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CRTAP, P3H1, and cyclophilin B (PPIB) comprise the collagen prolyl 3-hydroxylation complex in the ER. Absence of CRTAP or P3H1 leads to overmodification of the type I collagen helical region (by lysyl hydroxylase and prolyl 4-hydroxylase), indicating substantially delayed collagen helix folding.\",\n      \"method\": \"Biochemical collagen analysis from patient cells and Crtap-/- mice; SDS-PAGE migration shift assay for collagen overmodification\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated across multiple labs and patient cohorts using biochemical collagen modification assays\",\n      \"pmids\": [\"19862557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CRTAP and P3H1 are required to maintain a stable complex that 3-hydroxylates Pro986 in clade A collagen chains (types I, II, and V). Loss of CRTAP also abolishes 3-hydroxylation at Pro986 in α2(V) chains, but does not affect 3-hydroxylation at two known sites in α1(IV) chains, indicating substrate specificity of the complex for fibrillar collagens.\",\n      \"method\": \"Mass spectrometry-based collagen hydroxyproline analysis from Crtap-/- mouse tissues (lung, kidney) and human OI fibroblasts\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — MS-based site-specific hydroxylation mapping in mouse KO and human patient cells, replicated substrate specificity finding\",\n      \"pmids\": [\"20485499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CRTAP deficiency reduces deposition of type I collagen into the extracellular matrix (to 10–15% of control) and causes disorganization of the fibrillar network and increased collagen fibril diameters, demonstrating a chaperone/matrix-assembly role for CRTAP beyond intracellular hydroxylation.\",\n      \"method\": \"Immunofluorescence of long-term fibroblast cultures, quantitative pulse-chase experiments, electron microscopy of dermal collagen fibrils\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal methods (pulse-chase and immunofluorescence) in a single patient cell line\",\n      \"pmids\": [\"21955071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In zebrafish lacking crtap (CRISPR/Cas9 knockout), type I collagen is intracellularly overmodified and partially retained in enlarged ER cisternae, and extracellular collagen assembles into disorganized fibers with altered fibril diameter, supporting the complex's primary role as a collagen chaperone rather than solely a hydroxylase.\",\n      \"method\": \"CRISPR/Cas9 knockout zebrafish, transmission electron microscopy, collagen biochemical analysis\",\n      \"journal\": \"Matrix biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple orthogonal readouts (EM ultrastructure, biochemical modification analysis) in a vertebrate model\",\n      \"pmids\": [\"32173581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Deep intronic CRTAP mutations generate unstable truncated/aberrant isoforms containing a 'GWxxI' degron sequence, leading to protein instability, loss of Pro986 hydroxylation, type I collagen aggregation, and cell death by senescence. Collagen aggregates are partially cleared by autophagy.\",\n      \"method\": \"Genome sequencing, minigene splicing assay, western blot of patient cells, collagen aggregation assay, autophagy inhibition experiments\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single patient cell line, multiple biochemical methods but not independently replicated\",\n      \"pmids\": [\"37146916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Human CRTAP (CASP) encodes a novel cartilage-associated protein with high sequence identity to mouse and lower identity to chick orthologs; the gene is expressed in cartilage and maps to chromosome 3p22; CRTAP protein is related to but distinct from certain nuclear proteins, defining a new protein family.\",\n      \"method\": \"cDNA cloning, Northern blot, FISH chromosome mapping, immunohistochemistry\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct experimental characterization including FISH mapping and immunohistochemistry in multiple tissues\",\n      \"pmids\": [\"10702664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CRTAP deficiency (in Crtap-/- mice and OI type VII patients) results in significantly elevated bone matrix mineral content and altered mineralization kinetics, with increased proportions of highly mineralized matrix and primary bone persistence, indicating that abnormal collagen modification secondary to CRTAP loss directly perturbs bone mineralization.\",\n      \"method\": \"Quantitative backscattered electron imaging (qBEI) of mouse femurs and human bone biopsies\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative imaging in both mouse KO and human patient biopsies, consistent findings across species\",\n      \"pmids\": [\"19895918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Crtap-/- mouse tendons show reduced collagen fibril size, increased collagen cross-links, and altered progenitor cell populations, with dysregulated TGF-β, inflammatory, and metabolic signaling by RNA-seq, and increased αSMA, MMP2, and phospho-NFκB staining indicating excess matrix remodeling and tissue inflammation.\",\n      \"method\": \"Mechanical testing of isolated tendons, electron microscopy, RNA-seq, immunostaining, flow cytometry of tendon progenitor cells, behavioral motor testing\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods in mouse KO model, single lab\",\n      \"pmids\": [\"34036937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Biallelic CRTAP mutations reduce CRTAP mRNA and protein in osteoblasts, leading to significantly reduced prolyl 3-hydroxylation at Pro986 of the α1(I) collagen chain, reduced osteoid volume, and reduced osteoblast numbers, directly linking CRTAP function in osteoblasts to active bone formation.\",\n      \"method\": \"Bone biopsy immunostaining, RT-PCR, western blot, mass spectrometry of collagen hydroxylation in patient osteoblasts\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct patient bone specimen analysis with multiple methods but single patient sample\",\n      \"pmids\": [\"38214665\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CRTAP is an essential non-enzymatic scaffold component of the ER-resident P3H1/CRTAP/PPIB ternary complex, which—as revealed by cryo-EM—positions the P3H1 hydroxylase and PPIB isomerase active sites in a face-to-face bifunctional reaction center to perform coupled prolyl 3-hydroxylation and cis-trans isomerization of Pro986 in fibrillar (clade A: type I, II, V) collagen α1 chains; CRTAP and P3H1 mutually stabilize each other post-translationally via proteasome-dependent degradation when either partner is absent, and loss of CRTAP additionally impairs collagen chaperoning, causing intracellular collagen overmodification, delayed helix folding, deficient extracellular matrix deposition, and disorganized collagen fibrils, collectively producing the severe recessive osteogenesis imperfecta (type VII) phenotype.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CRTAP is an essential ER-resident component of the collagen prolyl 3-hydroxylation machinery, where it assembles with the P3H1 hydroxylase and the PPIB (cyclophilin B) isomerase into a ternary complex that modifies fibrillar collagen during biosynthesis [#2, #3]. Cryo-EM of the P3H1/CRTAP/PPIB complex shows the P3H1 and PPIB active sites arranged face-to-face into a bifunctional reaction center with a multi-site collagen substrate-interacting zone, defining a coupled hydroxylation–isomerization mechanism [#0]. The complex 3-hydroxylates Pro986 of clade A (type I, II, V) collagen α1 chains, and loss of CRTAP abolishes this site-specific modification while leaving non-fibrillar α1(IV) sites unaffected, establishing its substrate specificity [#4]. CRTAP and P3H1 mutually stabilize one another post-translationally: absence of either triggers proteasome-mediated degradation of the partner, and re-expression restores both protein levels and Pro986 hydroxylation [#1]. Beyond hydroxylation, CRTAP acts as a collagen chaperone; its loss causes intracellular collagen overmodification and delayed helix folding, ER retention and aggregation, deficient extracellular matrix deposition, and disorganized fibrils of altered diameter [#3, #5, #6]. These defects perturb bone mineralization and osteoblast-driven bone formation, and biallelic CRTAP mutations produce a severe recessive osteogenesis imperfecta phenotype [#9, #11].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established CRTAP as a novel cartilage-expressed protein and defined it as a new gene/protein family, providing the molecular entity later linked to collagen biology.\",\n      \"evidence\": \"cDNA cloning, Northern blot, FISH mapping to 3p22, and immunohistochemistry across tissues\",\n      \"pmids\": [\"10702664\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical function assigned at this stage\", \"No interaction partners identified\", \"Relationship to collagen modification unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showed CRTAP is not an isolated protein but part of a complex with P3H1 that 3-hydroxylates Pro986 in α1(I)/α1(II) collagen and recruits cyclophilin B, defining its catalytic context.\",\n      \"evidence\": \"Biochemical collagen analysis of patient fibroblasts carrying CRTAP loss-of-function mutations\",\n      \"pmids\": [\"18566967\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"CRTAP's own enzymatic role within the complex not resolved\", \"Stoichiometry and assembly mechanism unknown\", \"No structural basis for catalysis\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Resolved how CRTAP and P3H1 depend on each other by demonstrating reciprocal post-translational stabilization, explaining why mutation in one gene eliminates both proteins.\",\n      \"evidence\": \"Western blot, immunofluorescence, transfection rescue, and proteasome inhibition in patient fibroblasts; biochemical collagen overmodification analysis in patient cells and Crtap-/- mice\",\n      \"pmids\": [\"19846465\", \"19862557\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The degradation signal/machinery targeting the unstabilized partner not defined\", \"Quantitative contribution of hydroxylation vs folding delay to overmodification unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined the substrate range of the CRTAP-containing complex by mapping which collagen Pro residues require CRTAP, establishing specificity for fibrillar (clade A) collagens.\",\n      \"evidence\": \"Mass spectrometry hydroxyproline mapping in Crtap-/- mouse tissues and human OI fibroblasts\",\n      \"pmids\": [\"20485499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of site selectivity within collagen sequences not defined\", \"Whether CRTAP contributes binding specificity vs P3H1 unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended CRTAP's role beyond hydroxylation to matrix assembly, showing its loss reduces ECM collagen deposition and disorganizes the fibrillar network, implicating a chaperone function.\",\n      \"evidence\": \"Immunofluorescence, quantitative pulse-chase, and electron microscopy in patient fibroblasts\",\n      \"pmids\": [\"21955071\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single patient cell line\", \"Molecular basis of chaperone activity not defined\", \"Whether matrix defect is direct or secondary to overmodification unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Confirmed the chaperone-dominant role in a vertebrate genetic model, showing intracellular collagen overmodification, ER retention, and disorganized extracellular fibrils upon crtap loss.\",\n      \"evidence\": \"CRISPR/Cas9 crtap-knockout zebrafish with TEM and collagen biochemical analysis\",\n      \"pmids\": [\"32173581\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative weighting of hydroxylase vs chaperone contributions to phenotype not quantified\", \"Mechanism of ER retention not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified a degron-based mechanism by which deep intronic mutations destabilize CRTAP, linking protein instability to collagen aggregation, senescence, and autophagic clearance.\",\n      \"evidence\": \"Genome sequencing, minigene splicing assays, western blot, collagen aggregation and autophagy inhibition experiments in patient cells\",\n      \"pmids\": [\"37146916\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single patient cell line, not independently replicated\", \"Generality of the GWxxI degron to other variants unknown\", \"Mechanistic basis of senescence not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Provided the structural basis of CRTAP function, showing it scaffolds P3H1 and PPIB active sites into a face-to-face bifunctional center, revealing a coupled hydroxylation–isomerization mechanism.\",\n      \"evidence\": \"Cryo-EM of the P3H1/CRTAP/PPIB ternary complex with collagen peptide co-complex and active-site mutagenesis\",\n      \"pmids\": [\"39245686\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of the observed dual-ternary complex equilibrium not established\", \"Catalytic order/coupling kinetics not measured\", \"CRTAP's direct contribution to substrate binding vs scaffolding not separated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Tied CRTAP function directly to bone-forming cells, showing reduced osteoblast hydroxylation activity, osteoid volume, and osteoblast number in patient bone.\",\n      \"evidence\": \"Bone biopsy immunostaining, RT-PCR, western blot, and mass spectrometry of collagen hydroxylation in patient osteoblasts\",\n      \"pmids\": [\"38214665\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single patient sample\", \"Causal chain from collagen defect to reduced osteoblast number not resolved\", \"Cell-autonomous vs systemic effects not separated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CRTAP's distinct activities — scaffolding the bifunctional reaction center, mutual stabilization of P3H1, and collagen chaperoning — are mechanistically separable and individually contribute to the osteogenesis imperfecta phenotype remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No separation-of-function alleles isolating hydroxylase vs chaperone roles\", \"Functional meaning of the dual-ternary complex equilibrium unknown\", \"Mechanism linking collagen defect to mineralization abnormality undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3, 6]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [5, 6]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 11]}\n    ],\n    \"complexes\": [\"P3H1/CRTAP/PPIB collagen prolyl 3-hydroxylation complex\"],\n    \"partners\": [\"P3H1\", \"PPIB\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}